This site is intended for healthcare professionals
Latest drug news
  • Home
  • /
  • News
  • /
  • 2022
  • /
  • 5
  • /
  • Johnson & Johnson updates U.S. COVID-19 Vaccine Fa...
News

Johnson & Johnson updates U.S. COVID-19 Vaccine Fact Sheet.

Read time: 1 mins
Published:7th May 2022

Following the update to the Fact Sheet, the Johnson & Johnson COVID-19 vaccine is now authorized in the U.S. for use in individuals 18 years of age and older for whom other FDA-authorized or approved COVID-19 vaccines are not accessible or clinically appropriate, as well as for individuals 18 years of age and older who elect to receive the Johnson & Johnson COVID-19 vaccine because they would otherwise not receive a COVID-19 vaccine.

This is consistent with the Advisory Committee on Immunization Practices (ACIP) recommendations by the U.S. Centers for Disease Control and Prevention (CDC) in December 2021 that express a clinical preference for individuals to receive an mRNA COVID-19 vaccine.

Condition: Coronavirus/COVID-19 Infection
Type: drug

Learning Zones

The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.